• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重大心血管不良事件幸存者复发的时间依赖性风险

Time-Dependent Risk for Recurrence in Survivors of Major Adverse Cardiovascular Events.

作者信息

Bermon Anderson, Trejo-Valdivia Belem, Molina Castaño Carlos Federico, Segura Angela M, Serrano Norma C

机构信息

Centro de Investigaciones, Fundación Cardiovascular de Colombia, Bucaramanga, COL.

Escuela de graduados, Universidad CES, Medellín, COL.

出版信息

Cureus. 2024 Apr 30;16(4):e59366. doi: 10.7759/cureus.59366. eCollection 2024 Apr.

DOI:10.7759/cureus.59366
PMID:38817508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11138715/
Abstract

INTRODUCTION

The prevalence of the population with a history of an occlusive cardiovascular event has been increasing in recent years, which means that a large number of patients will have a higher risk of presenting a fatal recurrence. The aim is to determine variables associated with time-to-recurrent cardiovascular events and analyze how changes in low-density lipoprotein cholesterol (LDL-C) levels during follow-up may be associated with this time-to-event.

MATERIALS AND METHODS

This is a prospective observational cohort study of 727 adults with a history of at least one occlusive cardiovascular event recruited at a referral hospital in northeastern Colombia. Data from a follow-up period of a maximum of 33 months (median 26 months) (one death) were used to define how clinical and sociodemographic variables impact the recurrence of major adverse cardiovascular events (MACE). Analyses were performed based on proportional hazard models and time-dependent hazard models.

RESULTS

Upon enrollment, 215 (30%) of the participants reported experiencing their most recent cardiovascular event within the preceding year. After two years, the recurrence rate was 12.38% (90/727). The risk of recurrence before two years was 3.9% (95% CI 2.7-5.6). In the multiple models, the presence of severe depression gives a Hazard Ratio of 8.25 (95% CI 2.98-22.86) and LDL ≥120 md/dl Hazard Ratio of 2.12 (95% CI 1.2 -3.9). It was found that LDL >120 mg/dl maintained over time increases the chances of recurrence by 1.7% (Hazard Ratio: 1.017, 95% CI 0.008-0.025).

CONCLUSIONS

The present study allows us to identify a profile of patients who should be treated promptly in an interdisciplinary manner to avoid recurrences of coronary events.

摘要

引言

近年来,有心血管闭塞事件病史的人群患病率一直在上升,这意味着大量患者出现致命复发的风险更高。目的是确定与复发性心血管事件发生时间相关的变量,并分析随访期间低密度脂蛋白胆固醇(LDL-C)水平的变化如何与该事件发生时间相关。

材料与方法

这是一项对哥伦比亚东北部一家转诊医院招募的727名有至少一次心血管闭塞事件病史的成年人进行的前瞻性观察队列研究。使用最长33个月(中位数26个月)(1例死亡)的随访期数据来确定临床和社会人口统计学变量如何影响主要不良心血管事件(MACE)的复发。基于比例风险模型和时间依赖性风险模型进行分析。

结果

入组时,215名(30%)参与者报告在过去一年内经历了最近一次心血管事件。两年后,复发率为12.38%(90/727)。两年前的复发风险为3.9%(95%CI 2.7-5.6)。在多模型中,重度抑郁症的存在使风险比为8.25(95%CI 2.98-22.86),LDL≥120 md/dl使风险比为2.12(95%CI 1.2-3.9)。发现随着时间推移LDL>120 mg/dl会使复发几率增加1.7%(风险比:1.017,95%CI 0.008-0.025)。

结论

本研究使我们能够确定应以跨学科方式及时治疗以避免冠心病事件复发的患者特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/a7a3d0069645/cureus-0016-00000059366-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/991737c4f898/cureus-0016-00000059366-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/26ef64ac47b6/cureus-0016-00000059366-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/573cfd5be373/cureus-0016-00000059366-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/ea94bb1e3e50/cureus-0016-00000059366-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/4e477f201b42/cureus-0016-00000059366-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/c703e32aa69a/cureus-0016-00000059366-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/a7a3d0069645/cureus-0016-00000059366-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/991737c4f898/cureus-0016-00000059366-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/26ef64ac47b6/cureus-0016-00000059366-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/573cfd5be373/cureus-0016-00000059366-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/ea94bb1e3e50/cureus-0016-00000059366-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/4e477f201b42/cureus-0016-00000059366-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/c703e32aa69a/cureus-0016-00000059366-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa61/11138715/a7a3d0069645/cureus-0016-00000059366-i07.jpg

相似文献

1
Time-Dependent Risk for Recurrence in Survivors of Major Adverse Cardiovascular Events.重大心血管不良事件幸存者复发的时间依赖性风险
Cureus. 2024 Apr 30;16(4):e59366. doi: 10.7759/cureus.59366. eCollection 2024 Apr.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Impact of Low Baseline Low-Density Lipoprotein Cholesterol on Long-Term Postdischarge Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.急性心肌梗死患者低基线低密度脂蛋白胆固醇对出院后长期心血管结局的影响。
J Am Heart Assoc. 2022 Sep 6;11(17):e025958. doi: 10.1161/JAHA.122.025958. Epub 2022 Aug 24.
4
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.使用新的美国心脏病学会/美国心脏协会胆固醇管理指南进行风险分类及其与急性冠状动脉综合征后依洛尤单抗治疗的关系。
Circulation. 2019 Nov 5;140(19):1578-1589. doi: 10.1161/CIRCULATIONAHA.119.042551. Epub 2019 Sep 2.
5
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.载脂蛋白 B、急性冠状动脉综合征后残余心血管风险和依洛尤单抗的作用。
Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30.
6
Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.在稳定型冠心病的中国人群中,预测心血管事件残余风险的血清高敏 C 反应蛋白和血脂的基线水平:一项前瞻性队列研究。
Lipids Health Dis. 2018 Dec 3;17(1):273. doi: 10.1186/s12944-018-0923-1.
7
Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.评估 LDL-C/HDL-C 比值对经皮冠状动脉介入治疗和药物洗脱支架置入术后急性冠脉综合征患者一年临床结局的预测价值。
Lipids Health Dis. 2019 Feb 2;18(1):40. doi: 10.1186/s12944-019-0979-6.
8
Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.依低密度脂蛋白胆固醇达标水平评估依洛尤单抗在急性冠脉综合征后的临床疗效和安全性:ODYSSEY OUTCOMES 试验的倾向评分匹配分析。
Circulation. 2021 Mar 16;143(11):1109-1122. doi: 10.1161/CIRCULATIONAHA.120.049447. Epub 2021 Jan 13.
9
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.在 10 年发生动脉粥样硬化性心血管疾病风险低的个体中,低密度脂蛋白胆固醇与心血管死亡率的长期关联。
Circulation. 2018 Nov 20;138(21):2315-2325. doi: 10.1161/CIRCULATIONAHA.118.034273.
10
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial.贝匹地酸对全因心血管事件的影响:CLEAR 结局随机临床试验的预设分析。
JAMA Cardiol. 2024 Mar 1;9(3):245-253. doi: 10.1001/jamacardio.2023.5155.

本文引用的文献

1
Obesity Paradox in the Intrahospital and Follow-Up Phases of the Acute Coronary Syndrome: A Meta-Analysis and Systematic Review.肥胖悖论在急性冠状动脉综合征的院内和随访阶段:荟萃分析和系统评价。
Cardiology. 2023;148(6):528-544. doi: 10.1159/000531985. Epub 2023 Aug 8.
2
Psychological and pharmacological interventions for depression in patients with coronary artery disease.冠心病患者抑郁的心理和药理学干预措施。
Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD008012. doi: 10.1002/14651858.CD008012.pub4.
3
Anhedonic Depression Is Not Associated With Risk of Recurrent Major Adverse Cardiac Events and All-Cause Mortality in Acute Coronary Syndrome Patients.
快感缺失性抑郁症与急性冠状动脉综合征患者复发性主要不良心脏事件和全因死亡率无关。
Ann Behav Med. 2023 Feb 4;57(2):155-164. doi: 10.1093/abm/kaab092.
4
Revascularization rates with coronary angioplasty and mortality in type 2 myocardial infarction: A meta-regression analysis.经皮冠状动脉介入治疗和 2 型心肌梗死死亡率与再血管化率:Meta 回归分析。
Am J Emerg Med. 2021 Sep;47:145-148. doi: 10.1016/j.ajem.2021.03.042. Epub 2021 Mar 20.
5
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
6
Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.他汀类药物治疗的已知心血管疾病患者的五年残余动脉粥样硬化性心血管疾病风险预测模型。
Am J Cardiol. 2020 Dec 15;137:7-11. doi: 10.1016/j.amjcard.2020.09.043. Epub 2020 Sep 28.
7
Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol.评估针对二级预防中坚持服用心血管药物的短信的疗效和安全性:txt2heart哥伦比亚随机对照试验方案
BMJ Open. 2019 Dec 8;9(12):e028017. doi: 10.1136/bmjopen-2018-028017.
8
Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome.基于2019年欧洲心脏病学会/欧洲动脉粥样硬化学会指南的急性冠状动脉综合征患者低密度脂蛋白胆固醇目标值达标情况及降脂治疗滴定
Eur J Prev Cardiol. 2020 Dec;27(19):2314-2317. doi: 10.1177/2047487319891780. Epub 2019 Dec 9.
9
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
10
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.在来自 21 个高收入、中等收入和低收入国家(PURE)的 155722 人中,可改变的风险因素、心血管疾病和死亡率:一项前瞻性队列研究。
Lancet. 2020 Mar 7;395(10226):795-808. doi: 10.1016/S0140-6736(19)32008-2. Epub 2019 Sep 3.